Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Facility Designs and Production Scales

Background ICH Guidance for Industry, Q7 (2016) Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients section 18.5 specifies that appropriate precautions should be taken to prevent potential viral contamination from pre-viral to post-viral removal/inactivation steps, but no direct ...